New Lung Cancer Treatment Could Replace Chemotherapy


Research on a new inhalable dry powder of a common chemotherapy drug encapsulated in nanoparticles shows it is more effective in treating lung cancer than the IV injection or solution form of the chemical. In an animal experiment over 80% of the mice survived over 90 days and over 70% survived 140 days when treated with the inhalable dry powder whereas none of the mice treated with the IV injection or solution form survived past 50 days. The researchers concluded “results show that this treatment method may not only increase someone’s survival rate but could also potentially be less toxic to the body.” The inhalable powder was also more effective in decreasing the amount and size of the tumors than in those treated with IV injections or solution.

More information is available at:

Tags: , , , , ,

Comments are closed.